首页 | 本学科首页   官方微博 | 高级检索  
     


The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma
Authors:Kerstin Müller  Sanjit Datta  Sonja Gehrisch  Moiz Ahmad  Mohammed Ahmed Abdelrazek Mohammed  Jarrett Rosenberg  Gloria L. Hwang  John D. Louie  Daniel Y. Sze  Nishita Kothary
Affiliation:1. Stanford University School of Medicine, Stanford, California;2. Siemens Medical Solutions, Inc, Malvern, Pennsylvania;3. Siemens Healthcare GmbH, Forchheim, Germany;4. Stanford Health Care, Stanford, California;5. Theodor Bilharz Research Institute, Giza, Egypt
Abstract:

Purpose

To identify computational and qualitative features derived from dual-phase cone-beam CT that predict short-term response in patients undergoing transarterial chemoembolization for hepatocellular carcinoma (HCC).

Materials and Methods

This retrospective study included 43 patients with 59 HCCs. Six features were extracted, including intensity of tumor enhancement on both phases and characteristics of the corona on the washout phase. Short-term response was evaluated by modified Response Evaluation Criteria in Solid Tumors on follow-up imaging, and extracted features were correlated to response using univariate and multivariate analyses.

Results

Univariate and multivariate analyses did not reveal a correlation between absolute and relative tumor enhancement characteristics on either phase with response (arterial P = .21; washout P = .40; ? P = .90). On multivariate analysis of qualitative characteristics, the presence of a diffuse corona was an independent predictor of incomplete response (P = .038) and decreased the odds ratio of objective response by half regardless of tumor size.

Conclusions

Computational features extracted from contrast-enhanced dual-phase cone-beam CT are not prognostic of response to transarterial chemoembolization in patients with HCC. HCCs that demonstrate a diffuse, patchy corona have reduced odds of achieving complete response after transarterial chemoembolization and should be considered for additional treatment with an alternative modality.
Keywords:CI  confidence interval  CR  complete response  HCC  hepatocellular carcinoma  HU  Hounsfield unit  mRECIST  modified Response Evaluation Criteria in Solid Tumors  PD  progressive disease  PR  partial response  ROI  region of interest  SD  stable disease
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号